Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares OutstandingShares Outstanding
Ratios

Jupiter Neurosciences (JUNS) EBIAT (2024 - 2025)

Jupiter Neurosciences (JUNS) has disclosed EBIAT for 2 consecutive years, with -$2.6 million as the latest value for Q4 2025.

  • Quarterly EBIAT fell 68.56% to -$2.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$8.6 million through Dec 2025, down 254.35% year-over-year, with the annual reading at -$8.6 million for FY2025, 254.35% down from the prior year.
  • EBIAT for Q4 2025 was -$2.6 million at Jupiter Neurosciences, down from -$2.3 million in the prior quarter.
  • The five-year high for EBIAT was $313123.0 in Q2 2024, with the low at -$2.6 million in Q4 2025.